C12R 1 - Micro-organisms - Patents Sitemap

Patents for C12R 1 - Micro-organisms (92,025)
12/2002
12/27/2002	WO2002103002A2 Gene associated with leishmania parasite virulence
12/27/2002	WO2002102824A2 Method for specific fast detection of relevant bacteria in drinking water
12/27/2002	WO2001085905A3 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof
12/27/2002	CA2451053A1 Method for specific fast detection of relevant bacteria in drinking water
12/26/2002	US20020197683 Metabolic controlled fermentation process for carbamoyl tobramycin production
12/26/2002	US20020197675 Glial nerovus system modulator for use in the treatment of nervous system disorders and spine damage
12/26/2002	US20020197666 Human chordin-related proteins and polynucleotides encoding them
12/26/2002	US20020197655 Antigen and monoclonal antibody which recognizes the antigen
12/26/2002	US20020197654 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
12/26/2002	US20020197627 Monitoring protein interaction and activities in cell; obtain mating yeast cells, mixing, incubate with modulate, evaluate cell activity
12/26/2002	US20020197605 Novel Polynucleotides
12/26/2002	US20020197280 Method for the determination of prosthetic infections
12/26/2002	US20020197255 Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
12/25/2002	CN1387577A Process for producing product contg. antihypertensive tripeptides
12/25/2002	CN1387576A Sequence-specific DNA recombination in ekaryotic cells
12/25/2002	CN1387564A Lactobacillus helvetius producing antihypertensive di- and tripeptides
12/25/2002	CN1387442A Oral recombinant lactobacilli vaccines
12/25/2002	CN1097039C Production of D-pantoic acid and D-pantothenic acid
12/24/2002	US6498243 Epimorphin antagonist and process for producing it
12/24/2002	US6498233 Nucleic acid transfer system
12/24/2002	US6498028 Method for enriching and isolating bacteria which aerobically degrades PCNB
12/24/2002	US6498020 Fusion proteins comprising coiled-coil structures derived of bovine IF1 ATPase inhibitor protein
12/24/2002	US6497871 Polypeptide having anti-viral and anti-proliferative activity
12/24/2002	CA2280994C O-demethylation of pharmaceutical intermediates using microorganism of the genus monosporium or thamnostylum
12/24/2002	CA2087261C Purification directed cloning of peptides
12/24/2002	CA2070182C Chimeric immunoglobulin for cd4 receptors
12/24/2002	CA2065404C Assays and reagents for amyloid deposition
12/24/2002	CA2061636C Chimeric gene for the transformation of plants
12/24/2002	CA2042093C Cell line carrying an excess of mammalian centromeres
12/19/2002	WO2002101093A1 Method of determining dna base sequence
12/19/2002	WO2002101074A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
12/19/2002	WO2002101032A1 Mutant rna polymerases
12/19/2002	WO2002101017A2 A mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a vla-4 receptor
12/19/2002	WO2002101006A2 Production of proteins in plants
12/19/2002	WO2002068603A3 Materials and methods for the induction of premature chromosome condensation
12/19/2002	WO2002044360A3 Modified arginine deiminase
12/19/2002	WO2001075077A8 Isolation and expression of a gene for a nitrilase from acidovorax facilis 72w
12/19/2002	WO2001070032A9 Recombinant parainfluenza virus expression systems and vaccines
12/19/2002	WO2001004335A3 Human-bovine chimeric respiratory syncytial virus vaccines
12/19/2002	US20020194632 Transgenic knockouts of BACE-1
12/19/2002	US20020193561 P53 protein variants and therapeutic uses thereof
12/19/2002	US20020193316 Caloporoside derivatives, methods of their preparation and use
12/19/2002	US20020193293 Low oxygen affinity mutant hemoglobins
12/19/2002	US20020192826 Recombinant AAV vector-based transduction system and use of same
12/19/2002	US20020192801 Human uridine diphosphate galactose-4-epimerase
12/19/2002	US20020192788 Preferential kinase for use in generation of nucleoside monophosphates
12/19/2002	US20020192782 Enzymatic polypeptide for use in the generation of pharmeceuticals
12/19/2002	US20020192772 Generation of glutamic acid by fermentation; obtain microorganism, incubate in nutrient broths, recover glutamic acid
12/19/2002	US20020192760 Nucleotide sequences coding membrane protein for use the diagnosis and treatment of asthma, parkinson's, heart defects, hypotension, urogenital disorders
12/19/2002	US20020192705 Clonal expansion of T cells of unknown specificity and identification of ligand recognized by the clonally expanded T cells
12/19/2002	US20020192237 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions
12/19/2002	US20020192228 Protein markers for lung cancer and use thereof
12/19/2002	US20020192197 Wound repair dressings and methods for their preservation
12/19/2002	US20020192191 Wound repair dressings and methods for their preservation
12/19/2002	CA2450320A1 Dna sequencing method
12/19/2002	CA2450319A1 Mutant rna polymerases
12/19/2002	CA2450019A1 Production of proteins in plants
12/19/2002	CA2449279A1 A mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a vla-4 receptor
12/19/2002	CA2447658A1 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
12/18/2002	EP1266965A2 Recombinant antibodies for human therapy
12/18/2002	EP1266962A2 Method for producing amide compounds
12/18/2002	EP1266960A1 Method and apparatus for culturing cell or tissue
12/18/2002	EP1266023A2 LIPOPOLYSACCHARIDES (LPS) EXTRACTED FROM i ESCHERICHIA COLI /i
12/18/2002	EP1266011A1 Fungal transcriptional activator useful in methods for producing polypeptides
12/18/2002	EP1265480A1 Chimeric animal model susceptible to human hepatitis c virus infection
12/18/2002	EP0934431B1 Method and cellculture for identifying inhibitors of eukaryotic cell processes
12/18/2002	EP0789583B1 Methods and kits using macrophage stimulating protein
12/18/2002	EP0736002B9 Compound capable of introducing at least one molecule into a cell
12/18/2002	EP0726944B1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same
12/18/2002	EP0641385B1 Development of dna probes and immunological reagents of human tumor associated antigens
12/18/2002	EP0521996B1 Catalytic antibody components
12/18/2002	CN1385532A Expression system utilizing self-schizolysis fusing protein and novel reduction polypeptide
12/18/2002	CN1385529A Expression system utilizing self-schizolysis fusing protein and novel reduction polypeptide
12/18/2002	CN1096500C Process for the preparation of pyruvic acid
12/17/2002	US6495742 Stress tolerant plants; genetic engineering
12/17/2002	US6495738 Aspergillus; genetic engineering
12/17/2002	US6495735 Transgenic non-human mammals expressing DNA sequences encoding homologous complement restriction factors of a discordant mammalian species
12/17/2002	US6495666 Polypeptide composing human chimeric antibody
12/17/2002	US6495519 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
12/17/2002	US6495354 Synthases
12/17/2002	US6495332 Methods and compositions for ameliorating the symptoms of sepsis
12/17/2002	CA2214439C A novel growth factor and a genetic sequence encoding same
12/17/2002	CA2080260C Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof
12/17/2002	CA2047833C Cloning of the biosynthetic pathway genes for chlortetracycline production from streptomyces aureofaciens and their expression in steptomyces lividans
12/17/2002	CA1341411C Method for producing fv fragments in eukaryotic cells
12/17/2002	CA1341410C Recombinant acquired immune deficiency syndrome (aids) viral envelope protein and method of testing for aids
12/17/2002	CA1341409C Cloning and expression of htlv-iii dna
12/12/2002	WO2002099034A2 Sequences for detection and identification of methicillin-resistant staphyloccocus aureus
12/12/2002	WO2002074798A3 The genome of a bifidobacterium
12/12/2002	WO2002034891A3 Immortalized preosteoblasts and method for their production
12/12/2002	WO2001095922A1 Remedies for allergic diseases and process for producing the same
12/12/2002	WO2001027303A9 Adeno-associated virus vectors encoding factor viii and methods of using the same
12/12/2002	WO2000032152A3 Compositions and methods for regulating bacterial pathogenesis
12/12/2002	US20020187946 Mammalian iap gene family, primers, probes and detection methods
12/12/2002	US20020187930 Substances and their uses
12/12/2002	US20020187537 Culture product; polypeptide
12/12/2002	US20020187535 Enzymatic polypeptide for use in the treatment of emphysema, adult respiratory distress syndrome and psoriasis
12/12/2002	US20020187532 Generation of nerolidol; obtain genetically enginerred cells, express vector, recover nerolidol
12/12/2002	US20020187530 Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids
12/12/2002	US20020187527 Generation of nucleotide sequence which can be used as tools of gene therapy; obtain cells, transform with expression vector, recover transformed cells, detect methyltransferase expression and methylated nucleotide sequences

1 ... 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 ... 921